GNLX

GENELUX CORP

GNLX·36870H103·US·Common Stock·Healthcare - Biotechnology-13D/G

GNLX (GENELUX CORP) is held by 38 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5M), BlackRock, Inc. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($1.3M). Net institutional sentiment: Mixed.

38
Holders
(2 Elite)
$13.3M
Total Value
50% (34)
Consensus
17 buying - 17 selling
13F: Insider & Congress: Updated regularly
GNLX

Smart Money Verdict

View all
Loading verdict
Held by 38 funds
2 elite

Who's Trading

Source dates: Price Sep 18, 2026 · Insiders Sep 2, 2026 · Activists Feb 17, 2026 · Congress none

InsiderCJCappello JosephSell $28KAug 31, 2026
InsiderZTZindrick ThomasSell $92KAug 31, 2026
InsiderYYYu YongSell $27KAug 31, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
1.7M(-1.1%)$5M0.0%-4.26%
0
Increased
439,602(+8.3%)$1.3M0.0%-9.03%
19
Decreased
439,213(-3.2%)$1.3M0.0%-81.13%
0
Increased
328,803(+1.5%)$989,6970.0%-11.24%
25
Decreased
236,344(-6.1%)$711,3950.0%-4.26%
0
Increased
157,857(+13.5%)$475,1500.0%-66.33%
27
Unchanged
145,850$439,0090.0%-70.67%
0
Increased
121,958(+2.5%)$367,0910.0%-18.95%
24
Increased
105,229(+762.5%)$316,7390.0%-21.32%
38
Decreased
89,279(-45.7%)$268,7300.0%-75.21%
0
New
85,481$257,2980.0%-17.94%
35
Decreased
83,543(-5.1%)$251,4640.0%-20.80%
0
Increased
52,866(+89.7%)$159,1270.0%-11.26%
35
New
45,881$138,1020.0%-17.94%
31
Increased
45,809(+40.5%)$137,8850.0%-36.29%
20
Decreased
44,794(-1.7%)$134,8300.0%-1.59%
0
Unchanged
41,000$124,2300.0%-40.74%
0
Increased
39,539(+72.4%)$119,0120.0%-34.68%
33
Decreased
34,995(-71.5%)$105,3350.0%-30.74%
0
Unchanged
30,758$92,5810.0%-10.26%
0

Showing 1-20 of 41

1 / 3
GNLXGNLXGENELUX CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used